Longitudinal analysis of hsa-miR-3163, hsa-miR-124-3p, hsa-miR-548c-3p, and hsa-miR-27a-3p as prognostic biomarkers in HIV-infected patients
Our findings highlight the potential of miR-3163 as a robust prognostic biomarker for monitoring HIV progression and optimizing ART strategies. Validation in larger cohorts is warranted to confirm its clinical utility.
Authors
- Umut Can Küçüksezer (ORCID: https://orcid.org/0000-0002-5358-5570)
- Bilgül Mete (ORCID: https://orcid.org/0000-0001-9091-6087)
- Muhammad Ihtisham Umar (ORCID: https://orcid.org/0000-0001-5980-4853)
- Burhaneddin Oktan (ORCID: https://orcid.org/0000-0001-7246-7556)
- Fehmı Tabak (ORCID: https://orcid.org/0000-0001-8632-2825)
- İ̇lker İnanç Balkan (ORCID: https://orcid.org/0000-0002-8977-5931)
- Haktan Sönmez (ORCID: https://orcid.org/0000-0001-7566-2170)
- Günnur Deniz (ORCID: https://orcid.org/0000-0002-0721-6213)
- Andleeb Shahzadi
Institutions
- COMSATS University Islamabad (PK)
- HUN-REN Institute of Experimental Medicine (HU)
- Istanbul University-Cerrahpaşa (TR)
- Istanbul University (TR)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.3389/fimmu.2025.1565068
- Citations
- 1
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Istanbul Üniversitesi